Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes, however, are placed in growth factors that show neuroprotective abilities (e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF)) and in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobuś, Anna, Baumert, Bartłomiej, Litwińska, Zofia, Gołąb-Janowska, Monika, Stępniewski, Jacek, Kotowski, Maciej, Pius-Sadowska, Ewa, Kawa, Miłosz P., Gródecka-Szwajkiewicz, Dorota, Peregud-Pogorzelski, Jarosław, Dulak, Józef, Nowacki, Przemysław, Machaliński, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983708/
https://www.ncbi.nlm.nih.gov/pubmed/29702606
http://dx.doi.org/10.3390/ijms19051312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983708/
https://www.ncbi.nlm.nih.gov/pubmed/29702606
http://dx.doi.org/10.3390/ijms19051312

Ejemplares similares